Actylis – The Partner of Choice

Activities: Manufacturing Ingredients Research & Development

Trending Articles

  1. NICE approves KEYTRUDA as first perioperative immunotherapy for locally advanced head and neck cancer MSD's KEYTRUDA (pembrolizumab) has received NICE approval as a neoadjuvant and adjuvant therapy for resectable LA HNSCC—the first immunotherapy recommended in this...
  2. Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy Roche has initiated a new Phase III study of Elevidys, aiming to generate placebo-controlled data for European Medicines Agency resubmission and expand access to the Duchenne...
  3. OpenAI launches GPT-Rosalind to accelerate life sciences research and drug discovery workflows The new AI model designed for biochemistry, genomics and pharmaceutical R&D aims to speed early-stage discovery while maintaining security and governance in regulated environments
  4. Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery...
  5. Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets
Manufacturing

Actylis appoints Scott Thomson as CEO

Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Distribution

Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride

The two companies aim to expand the distribution of benzalkonium chloride within Europe
Manufacturing

Actylis adds a WFI production system in Canada

The manufacturer of raw materials has launched a Water for Injection (WFI) and additional ISO Class 7 manufacturing in Montreal, Canada
Manufacturing

Actylis opens 30,000 sqft cGMP API facility

The Eugene facility is the latest GMP manufacturing facility that Actylis has commissioned, along with the other GMP sites in Montreal, Limerick and Ahmedabad
Manufacturing

Actylis invests $450k in Manchester facility, UK

The modernisation work was completed during the summer of 2022
Manufacturing

The debut of Actylis signals the creation of a specialty ingredients manufacturing and sourcing powerhouse

The unique hybrid model provides unparalleled flexibility for individualised, customer-centric ingredient solutions along with exceptional supply chain dependability
Subscribe now